Fibromyalgia: How to Test for It and What Fibro Testing Really Means

Short Answer

If you searched “fibromyalgia how to test” or “fibro testing,” the key point is simple: there is no single test. Fibromyalgia is a clinical diagnosis. A clinician looks at your history, examines you, scores widespread pain with the Widespread Pain Index (WPI), rates fatigue, unrefreshing sleep, and cognitive symptoms with the Symptom Severity Scale (SSS), checks the required symptom duration, and rules out other conditions. Bloodwork and imaging do not confirm fibromyalgia; they help exclude look-alikes.

Welltory’s own data makes the same point from the other direction: across 299 users who self-reported a fibromyalgia diagnosis, everyday wearable numbers — morning HRV score and sleep score — were essentially indistinguishable from other users, and the distributions overlapped almost completely. There is no single objective number that identifies fibromyalgia, which is exactly why the diagnosis rests on clinical criteria rather than a device reading.

Fibromyalgia Diagnostic Criteria at a Glance

Scoring and thresholds are from the American College of Rheumatology criteria — the 2010 preliminary criteria and their 2016 revision (Wolfe et al., 2016 Revisions to the 2010/2011 Fibromyalgia Diagnostic Criteria). Clinic overviews (Mayo, NIAMS) describe the same framework but the exact scores come from the ACR criteria papers.

How Fibromyalgia Is Diagnosed: Tests and Tools Compared

There Is No Single Test — Fibromyalgia Is a Clinical Diagnosis

If your labs came back normal, that does not rule out fibromyalgia. In fibromyalgia, routine tests can be normal because the condition is not confirmed by a blood marker, scan, or single objective measurement. The workup is different: your clinician looks for a recognizable pattern in your body, your symptoms, and your timeline.

That is why the process can feel so frustrating. You may have severe pain, deep fatigue, poor sleep, and brain fog — while the tests used to rule out other conditions do not “prove” what you are feeling. A 2026 systematic review of chronic-pain conditions describes the problem directly, noting that “the lack of clinical biomarkers adds to the challenge of diagnosis and treatment” (Beyond the Pain: Rethinking Chronic Pain Management, PMC12897678).

The clinical picture is also complicated by overlap. A 2026 imaging study states that “the clinical diagnosis of fibromyalgia (FM), a syndrome characterized by generalized pain, is challenging due to its unknown etiology and frequent comorbidity with other diseases” (Machine learning for the diagnosis of fibromyalgia based on MRI, PMC12863509). In real life, that means your doctor has to ask: Is this fibromyalgia? Another condition? Or fibromyalgia plus something else?

Because there is no confirmatory lab test, clinicians use standardized criteria, most commonly the American College of Rheumatology criteria. Recent research still uses this framework — for example, a 2026 case-control study of post-COVID patients described participants as having “fibromyalgia diagnosed according to the 2016 American College of Rheumatology (ACR) criteria” (Association Between Post-COVID-19 Infection and Fibromyalgia, PMC12898185). The purpose of the criteria is to make a subjective symptom pattern more structured, repeatable, and clinically useful.

One note on search terms: “fibro testing” sometimes brings up FibroScan results online. FibroScan is a liver stiffness test (transient elastography), used to assess liver fibrosis — it is not a test for fibromyalgia.

The Two Scores That Define the Criteria: WPI and SSS

Modern fibromyalgia criteria are built around two scores: the Widespread Pain Index (WPI) and the Symptom Severity Scale (SSS). Your answers matter because fibromyalgia is not only about how much you hurt. It is also about where you hurt, how long the pattern has lasted, and whether symptoms such as fatigue, unrefreshing sleep, and cognitive trouble are part of the same picture.

The WPI counts how many defined body regions have been painful in the past week. It lists 19 painful areas, so the score ranges from 0 to 19 (ACR 2016 revision, Wolfe et al.).

The SSS rates the severity of core symptoms — fatigue, waking unrefreshed, and cognitive symptoms — plus the extent of other physical symptoms. Its cumulative score ranges from 0 to 12 (ACR 2016 revision).

To meet the criteria, the WPI and SSS need to reach a specified combination, symptoms must have been present at a similar level for the required duration, and another disorder should not better explain them. Under the 2016 revision, that combination is WPI ≥7 and SSS ≥5, or WPI 4–6 and SSS ≥9, together with generalized pain (pain in at least 4 of 5 body regions) and symptoms present for ≥3 months (ACR 2016 revision). The earlier 2010/2011 version used WPI 3–6 for the second branch; the 2016 revision raised that lower bound to 4 and added the generalized-pain criterion.

The body logic behind this system is important. Widespread pain suggests a nervous-system pattern rather than a single injured joint or muscle. Fatigue and unrefreshing sleep matter because poor recovery can amplify pain sensitivity. Cognitive symptoms matter because many people with fibromyalgia describe “fibro fog” as one of the most disabling parts of the condition.

What Changed: From Tender Points to a Questionnaire

For years, fibromyalgia diagnosis was strongly associated with 18 tender points — specific places on the body that a clinician pressed during an exam. The 1990 ACR classification criteria required widespread pain plus tenderness in at least 11 of 18 tender points (ACR 1990 Criteria for the Classification of Fibromyalgia, Wolfe et al., PubMed 2306288).

Those older frameworks are still part of the medical history of fibromyalgia. A 2026 survey of clinicians refers to “the international FM practice guidelines (1990 ACR, 2010 ACR, 2012 Canadian)” among recognized diagnostic and practice frameworks (Knowledge, perception and attitude toward fibromyalgia, PMC12871961).

The problem with tender points is that the exam depends heavily on how it is performed. How much pressure was applied? Was the person already flaring? Did the clinician check every point consistently? The 2010 ACR criteria shifted the focus toward a scored symptom questionnaire, and the 2011 modification made the approach more usable as a self-report tool. A 2026 combat-cohort study, for example, assessed fibromyalgia with “the 2011 questionnaire modification of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia” (New Onset of Fibromyalgia After Exposure to a Combat Environment, DOI 10.1002/acr.80008).

Today, a clinician may still check tenderness during a physical exam. But the tender-point count is no longer the central gatekeeper for diagnosis under the modern WPI + SSS approach.

Ruling Out the Look-Alikes: Why Bloodwork Still Matters

Bloodwork does not confirm fibromyalgia. It helps make sure your symptoms are not better explained by something else.

That distinction matters. If you have widespread pain and fatigue, a clinician may consider other common causes, including thyroid disease, anemia, vitamin D deficiency, rheumatoid arthritis, lupus and other autoimmune conditions, inflammatory disease, and sleep disorders. Which tests you need depends on your symptoms, exam, medical history, and risk factors.

This is why people often hear that fibromyalgia is a “diagnosis of exclusion.” That phrase can sound dismissive, but clinically it means something specific: doctors have to look for conditions that mimic fibromyalgia before they settle on fibromyalgia as the best explanation. The ACR framework includes the idea that symptoms should not be better explained by another disorder.

Fibromyalgia can also overlap with conditions that have their own diagnostic challenges, including ME/CFS, POTS and other forms of dysautonomia, and IBS. These conditions can share fatigue, unrefreshing sleep, post-exertional symptoms, dizziness, palpitations, gut symptoms, and pain sensitivity. Sorting out whether you have one condition or several is part of why diagnosis can take time.

Who Diagnoses Fibromyalgia — and Why It Can Take Years

Fibromyalgia is often diagnosed by a rheumatologist, but a primary-care physician can also apply the criteria. Depending on your symptoms, pain specialists, neurologists, sleep specialists, cardiologists, gastroenterologists, or mental health professionals may also be involved.

The process can be slow because fibromyalgia lives at the intersection of pain, sleep, nervous-system sensitivity, fatigue, and overlapping medical conditions. You may be sent from one specialist to another. You may have normal labs. You may be told to “wait and see.” None of that means your symptoms are not real.

Delayed recognition has consequences. A 2026 study of clinicians’ knowledge of fibromyalgia notes that “early diagnosis has been shown to improve outcomes, whereas delayed recognition often leads to prolonged suffering and increased healthcare costs” (Knowledge, perception and attitude toward fibromyalgia, PMC12871961). If it has taken years for someone to take your pain seriously, that reflects a known gap in recognition — not a failure on your part.

Turning Your Data Into Evidence for the Appointment

You cannot diagnose fibromyalgia yourself. A wearable cannot diagnose it either.

What tracking can do is make your pattern visible. Fibromyalgia diagnosis depends on a history: where pain shows up, how long it has been present, how fatigue and sleep behave, whether symptoms flare after stress or exertion, and whether the pattern has been stable enough over time to meet clinical criteria.

We looked at this in our own data, and it underlines why no single number can stand in for the clinical criteria. Among 299 Welltory users who self-report a fibromyalgia diagnosis (compared with 3,846 other users), everyday wearable summaries did not separate the two groups: median morning HRV score and median sleep score were essentially the same as everyone else’s, with the distributions overlapping about 80%. The one raw gap — resting heart rate roughly 3 bpm higher — mostly disappeared once we accounted for how many other conditions people reported, and about 78% of the self-reported fibromyalgia group sat squarely inside everyone else’s normal resting-HR range. In other words, the value of tracking is not a “fibromyalgia number”; it is the timeline — the flare-and-recovery pattern you can bring to a clinician. All figures are reported as anonymized, aggregated data; no individual user is identifiable, and self-reported fibromyalgia is not a clinical diagnosis.

A simple record can help your appointment become more concrete. For example, you might bring:

• a pain map or WPI-style symptom note

• days when pain was widespread versus localized

• sleep duration and sleep-quality trends

• resting heart rate trends

• HRV trends

• flare or crash days

• notes on exertion, stress, infection, or poor sleep before flares

• cognitive symptoms such as word-finding trouble or concentration problems

This data does not replace the WPI + SSS assessment. It does not rule out lupus, thyroid disease, anemia, sleep apnea, or other look-alikes. It gives your clinician a timeline — and that timeline can make a criteria-based conversation easier.

When Your Labs Are Normal but You’re Not

Normal bloodwork can be part of the fibromyalgia diagnostic path. It may mean your clinician has not found thyroid disease, anemia, inflammatory arthritis, autoimmune disease, or another explanation in the tests ordered so far. It does not mean the pain is imaginary.

If your pain, fatigue, unrefreshing sleep, and cognitive symptoms are persistent, ask your clinician whether the ACR criteria — including the WPI and SSS — have been applied. If your symptoms overlap with dizziness, palpitations, post-exertional crashes, gut symptoms, or severe sleep disruption, ask whether conditions such as POTS, ME/CFS, IBS, or sleep disorders also need evaluation.

The goal is not to force a label. The goal is to make sure the right clinical framework is used with a qualified clinician.

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data